Planning Stage

策划阶段

基本信息

  • 批准号:
    7516044
  • 负责人:
  • 金额:
    $ 2.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-29 至 2008-08-31
  • 项目状态:
    已结题

项目摘要

INITIAL PLANNING STAGE The P20 partnership between Hampton University and the University of Pittsburgh Cancer Institute will be a dynamic collaboration with ongoing evaluation of projects and prioritization of resource allocation. While the Co-Pi's have ultimate responsibility for the functioning of the partnership, they will be guided by advice and input from an Advisory Committee (IAC) comprised of internal advisors from both institutions and an outside expert with internationally recognized expertise in gene-environment interaction. Committee members were nominated by institutional leadership and/or selected for special expertise and programmatic involvement. Committee members have been drawn from several academic disciplines important in the development of a strong multidisciplinary partnership. Through leadership roles in their disciplines, they are well qualified to evaluate partnership projects, to identify strategies to surmount logistic obstacles, and to know of additional faculty or core resources that can spur the successful growth of projects. This experience should facilitate useful input into long term planning aimed at sustaining intra-institutional collaborations in molecular epidemiology and environmental oncology. Faculty members from Hampton and from Pittsburgh are well represented on the Advisory Committee, so that an understanding of how each institution works frames committee deliberations. All Committee members had been briefed on the collaboration and expressed a high level of enthusiasm for the partnership and its goal of promoting the success of minority cancer researchers. There are two subcommittees of the Advisory Committee that have distinct oversight and planning responsibilities. These are the Research Review Subcommittee (RRC) and the Career Development and Mentoring Committee (CDMC). Research Review Committee (RRC) ¿ This committee, Co-Chaired by Dr. Daniel Johnson from Pittsburgh and Dr. Mark Evans from Hampton, will evaluate assess the progress of the P20 pilot projects and through review of semiannual reports and through evaluation of an annual Project Presentation by the Coinvestigators of the pilots projects. Daniel Johnson, PhD, Co-Chair of the RRC is Associate Professor of Medicine at the University of Pittsburgh, a Co-Editor of the international journal, Leukemia, a recipient of ongoing support from NIH RO1 grants and a standing member of the "Drug Discovery and Molecular Pharmacology" NIH study section. He has also served as a regular member of the American Cancer Society study section and is a frequent leader of sections at the annual meeting of the American Society of Hematology. Dr. Johnson has also trained Hampton undergraduates engaged in summer research rotations in his laboratory. RRC Co-Chair Mark Davis. PhD, is Chair of the Biology Department of Hampton University. His research interest is in Population Science. Other members of the RRC include: Laura Niedernhofer. MD-PhD a NIH-funded expert in DNA repair with a focus on the intersection of DMA repair mechanisms and aging. She also Co-Directs the Research Basis of Medical Knowledge course for MD-PhD students at Pittsburgh and has frequently mentored undergraduate trainees.
初步规划阶段

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EMANUELA TAIOLI其他文献

EMANUELA TAIOLI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EMANUELA TAIOLI', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10302837
  • 财政年份:
    2021
  • 资助金额:
    $ 2.38万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10686192
  • 财政年份:
    2021
  • 资助金额:
    $ 2.38万
  • 项目类别:
1/2- Feasibility study to build a collaboration in genetics and genomic cancer research
1/2- 建立遗传学和基因组癌症研究合作的可行性研究
  • 批准号:
    10686191
  • 财政年份:
    2021
  • 资助金额:
    $ 2.38万
  • 项目类别:
1/2- Feasibility study to build a collaboration in genetics and genomic cancer research
1/2- 建立遗传学和基因组癌症研究合作的可行性研究
  • 批准号:
    10302836
  • 财政年份:
    2021
  • 资助金额:
    $ 2.38万
  • 项目类别:
World Trade Center Tissue Biobank
世界贸易中心组织生物库
  • 批准号:
    9607412
  • 财政年份:
    2018
  • 资助金额:
    $ 2.38万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10454172
  • 财政年份:
    2015
  • 资助金额:
    $ 2.38万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10022664
  • 财政年份:
    2015
  • 资助金额:
    $ 2.38万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10674512
  • 财政年份:
    2015
  • 资助金额:
    $ 2.38万
  • 项目类别:
Prostate Cancer Risk and Outcome in WTC respondents
世贸中心受访者的前列腺癌风险和结果
  • 批准号:
    8695439
  • 财政年份:
    2013
  • 资助金额:
    $ 2.38万
  • 项目类别:
Development of a vulnerability profile of the psychological sequelae of Hurricane
制定飓风心理后遗症的脆弱性概况
  • 批准号:
    9113131
  • 财政年份:
    2013
  • 资助金额:
    $ 2.38万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了